Medicalizing the Opioid Epidemic in the U.S. in the Era of Health Care Reform

Journal of Psychoactive Drugs

Volumn 49, Issue 2, 2017, Pages 95-101

  Smith, David E ^a,b,c,d,e,f  

^a MD Associates   (United States)

^b Alta Mira Recovery Programs   (United States)

^c Center Point Inc   (United States)

^d Muir Wood Adolescent and Family Services   (United States)

^e North Bay Recovery Center   (United States)

^f Haight Ashbury Free Clinics   (United States)

Author keywords

Affordable Care Act; heroin; opiates; opioid epidemic; parity; prescription drug misuse

Indexed keywords

NALOXONE; OPIATE; OXYCODONE; NARCOTIC ANALGESIC AGENT;

ARTICLE; AWARENESS; CRIMINAL BEHAVIOR; DRUG OVERDOSE; ECONOMIC ASPECT; GOVERNMENT; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; LAW; MEDICAID; MEDICALIZATION; MENTAL HEALTH; OPIATE ADDICTION; PRESCRIPTION; SUBSTANCE ABUSE; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; PRESCRIPTION DRUG MISUSE; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; YOUNG ADULT;

ANALGESICS, OPIOID; DELIVERY OF HEALTH CARE; DRUG OVERDOSE; HEALTH CARE REFORM; HUMANS; MEDICALIZATION; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; UNITED STATES; YOUNG ADULT;

EID: 85015176929     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2017.1295334     Document Type: Article

References (53)

1. Appuzo, M., 2014. Holder endorses proposal to reduce sentences in latest sign of shift. New York Times, March 13. https://www.nytimes.com/2014/03/14/us/politics/holder-endorses-proposal-to-reduce-drug-sentences.html?_r=0 (accessed January 12, 2017).
2. Bentel, D. J., and D. E., Smith. 1971a. The crisis of drugs, combat and the American soldier in Vietnam. Synapse 15:1 (28, May).
3. Bentel, D. J., and D. E., Smith. 1971b. The year of the middle class junkie. California Health, April, p. 1.
4. Beronio, K., R., Po, L., Skopec, and S., Glied. 2013. Affordable Care Act expands mental health and substance use disorder benefits and federal parity protections for 62 million Americans. U.S. Department of Health & Human Services, ASPE Brief. http://aspe.hhs.gov/health/reports/2013/mental/rb_mental.pdf.
5. Bonnie, R. J., A. M., Coughlin, J. C., Jeffries, and P. W., Low. 2004. Criminal law, 2nd ed. New York, NY:Foundation Press.
6. Centers for Disease Control and Prevention. 2015a. Injury prevention & control:Prescription drug overdose. Centers for Disease Control and Prevention. www.cdc.gov/drugoverdose/.
7. Centers for Disease Control and Prevention. 2015b. Today’s heroin epidemic. Centers for Disease Control and Prevention. www.cdc.gov/vitalsigns/heroin/.
8. Cicero, T. J., M. S., Ellis, H. L., Surratt, and S. P., Kurtz. 2014. The changing face of heroin use in the United States:A retrospective analysis of the past 50 years. JAMA Psychiatry 71 (7):821–26. doi:10.1001/jamapsychiatry.2014.366.
9. Clark, H. W., 2016. Community solutions to prescription drug abuse. Presentation, University of California, Berkeley, Extension, San Francisco, September 15.
10. DEA. 2016. Carfentanil:A dangerous new factor in the U.S. opioid crisis, officer safety alert. https://www.dea.gov/divisions/hq/2016/hq092216_attach.pdf (accessed January 12, 2017).
11. Dunlap, B., and A. S., Cifu. 2016. Clinical management of opioid use disorder. JAMA 316 (3):338–39. doi:10.1001/jama.2016.9795.
12. DuPont, R. L., 2016. A new public health strategy to turn back the heroin epidemic. Presentation, The Cosmos Club, Washington, DC, September 27.
13. DuPont, R. L., A. T., McLellan, G., Carr, M., Gendel, and G. E., Skipper. 2009a. How are addicted physicians treated? A national survey of physician health programs. Journal of Substance Abuse Treatment 37:1–7. doi:10.1016/j.jsat.2009.03.010.
14. DuPont, R. L., A. T., McLellan, W. L., White, L., Merlo, and M. S., Gold. 2009b. Setting the standard for recovery:Physicians health programs evaluation review. Journal of Substance Abuse Treatment 36 (2):159–71. doi:10.1016/j.jsat.2008.01.004.
15. Federal Drug Administration. 2016a. FDA basics webinar:A brief overview of risk evaluation and mitigation strategies (REMS). U.S. Food and Drug Administration. http://www.fda.gov/aboutfda/transparency/basics/ucm325201.htm (accessed September 20, 2016).
16. Federal Drug Administration. 2016b. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. Press announcements, August 31. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518697.htm.
17. Fellner, J., 2009. Decades of disparity:Drug arrests and race in the United States. Human Rights Watch. https://www.hrw.org/report/2009/03/02/decades-disparity/drug-arrests-and-race-united-states
18. Galanter, M., M., Seppala, and A., Klein. 2016. Medication-assisted treatment for opioid dependence in twelve step-oriented residential rehabilitation settings. Substance Abuse 37 (3):381–83. doi:10.1080/08897077.2016.1187241.
19. Gloucester [MA] Police Department. 2015. For addicts and their friends, families, and caregivers. http://gloucesterpd.com/addicts/.
20. Hawkins, D., 2016. A new front in the opioid war:Elephant tranquilizer. Washington Post, August 12, p. 1.
21. Health & Human Services. 2015. HHS takes strong steps to address opioid-drug related overdose, death and dependence. U.S. Department of Health & Human Services press release, March 26. http://www.hhs.gov/news/press/2015pres/03/20150326a.html.
22. Health and Human Services (HHS), Office of the Surgeon General. 2016, November. Facing addiction in America:The Surgeon General’s report on alcohol, drugs, and health. Washington, DC:HHS. https://addiction.surgeongeneral.gov/.
23. HealthRIGHT 360. 2015. Substance use disorder treatment. http://www.healthright360.org/services-offered/substance-use-disorder-treatment, not paginated.
24. Jones, C. M., 2013. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers:United States, 2002–2004 and 2008–2010. Drug and Alcohol Dependence 132:95–100. doi:10.1016/j.drugalcdep.2013.01.007.
25. Kennedy, E. J., 1920. The pharmaceutical era. New York, NY:D.O. Haynes & Co.
26. Leshner, A. I., 1999. Science-based views of drug addiction and its treatment. JAMA 282 (14):1314–16. doi:10.1001/jama.282.14.1314.
27. Liptak, A., 2015. Justices give Obama another health care victory. New York Times, June 26, A1, A14.
28. Miller, T., and D., Hendrie 2008. Substance abuse prevention dollars and cents:A cost-benefit analysis. DHHS Pub. No. (SMA) 07-4298. Rockville, MD:Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/sites/default/files/cost-benefits-prevention.pdf, p. 2.
29. Musto, D. F., 1999. The American disease:Origins of narcotic control, 3rd ed. New York, NY:Oxford University Press.
30. National Center for Biotechnology Information. 2005, 2016. Carfentanil. U.S. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/carfentanil#section=Top.
31. National Research Council. 2014. The growth of incarceration in the United States:Exploring causes and consequences. Washington, DC:The National Academies Press.
32. NIDA. 2008. Addiction science:From molecules to managed care:Drug abuse costs United States economy hundreds of billions of dollars in increased health costs, crime and productivity. http://www.drugabuse.gov/publications/addiction-science-molecules-to-managed-care/introduction/drug-abuse-costs-united-states-economy-hundreds-billions-dollars-in-increased-health, unpaginated.
33. rd ed. http://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/frequently-asked-questions/drug-addiction-treatment-worth-its-cost, 13.
34. NIH Pain Consortium. 2015. HHS pathways to safer opioid use. https://painconsortium.nih.gov/federal_Pain_Activities/pathwaystosaferopioiduse.html.
35. Office of National Drug Control Policy. 2014. National drug control strategy 2014. Executive Office of the President of the United States. https://www.whitehouse.gov/sites/default/files/ndcs_2014.pdf, 25, 29.
36. Podolin, R., 2016. Opioids, pain, addiction, and responsibility. San Francisco Medicine 89 (6):7.
37. Quest Diagnostics. 2016. Quest diagnostics health trends prescription drug monitoring report 2016:Prescription drug misuse in America:Diagnostic insights in the continuing drug epidemic battle. Madison NJ:Quest Diagnostics, 24p.
38. Reuter, P., 2013. Why has US drug policy changed so little over 30 years? Crime and Justice 42 (1):75–140. doi:10.1086/670818.
39. Samuels, M. 2016., Answer to opioid crisis:Treatment instead of jail. Boston University School of Public Health, March 17. http://www.bu.edu/sph/2016/03/17/looking-at-care-instead-of-jail-for-problem-close-to-home/ (accessed January 12, 2017).
40. Shear, M. D., 2015. U.S. budgets funds to treat heroin abuse in Northeast. New York Times, August 18, p. 1.
41. Sheppard, C. W., G. R., Gay, and D. E., Smith. 1971. The changing patterns of heroin addiction in the Haight-Ashbury subculture. Journal of Psychedelic Drugs 3 (2):22–30. doi:10.1080/02791072.1971.10471373.
42. Sherman, M., 2015. Supreme Court upholds nationwide health care law subsidies. Associated Press, June 25. http://www.aol.com/article/2015/06/25/supreme-court-upholds-nationwide-health-care-law-subsidies/21201159/, not paginated.
43. Smith, D. E., G. R., Gay, and C. W., Sheppard. 1974. The new junkie. Emergency Medicine 6 (2):117–26.
44. Smith, D. E., D. R., Lee, and L. D., Davidson. 2010. Health care equality and parity for treatment of addictive disease. Journal of Psychoactive Drugs 42 (2):121–26. doi:10.1080/02791072.2010.10400684.
45. Smith, J., and C., Medalia 2014. Health insurance coverage in the United States:2013. U.S. Census P60-250, 2. http://www.census.gov/content/dam/Census/library/publications/2014/demo/p60-250.pdf.
46. Substance Abuse and Mental Health Services Administration. 2014. Results from the 2013 National Survey on Drug Use and Health. Rockville, MD:Substance Abuse and Mental Health Services Administration.
47. U. S. Congress. 2008. H.R. 1424:Text of the Paul Wellstone Mental Health and Addiction Equity Act of 2007. https://www.govtrack.us/congress/bills/110/hr1424/text.
48. U.S. Congress. 2010. H.R. 3590:Text of the Patient Protection and Affordable Care Act. https://www.govtrack.us/congress/bills/111/hr3590/text.
49. U.S. Congress. 2016. S.524:Text of the Comprehensive Addiction and Recovery Act of 2016. https://www.congress.gov/bill/114th-congress/senate-bill/524 (accessed January 12, 2017).
50. Vestal, C., 2015. States gear up to help Medicaid enrollees beat addictions. Stateline. http://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2015/1/13/states-gear-up-to-help-medicaid-enrollees-beat-addictions.
51. Volkow, N., 2014. Prescription opioid and heroin abuse:Testimony to Congress, April 29, 2014. National Institute on Drug Abuse. http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2015/prescription-opioid-heroin-abuse.
52. Volkow, N., T., Frieden, P., Hyde, and S. S., Cha. 2014. Medication-assisted therapies:Tackling the opioid-overdose epidemic. New England Journal of Medicine 370:2063–66. doi:10.1056/NEJMp1402780.
53. Walmsley. 2013. World population list, 10th ed. London, England:International Centre for Prison Studies.